Buzz: Hungry AstraZeneca circles a blockbuster biosimilars buyout

John Carroll Quoting sources close to the deal, Korea's Financial News says that Celltrion hooked AstraZeneca's interest after it began to cast around for a merger deal a few ...

Report: Alexion allies with Goldman as Roche buyout rumor blazes

John Carroll If Roche actually comes through with a $ 22 billion-plus bid for Alexion, the biotech intends to be ready to man the defenses and fight it out for top dollar. FierceBiotech ...

Valeant to fire thousands, restructure ops after Bausch buyout

Tracy Staton Valeant Pharmaceuticals ($ VRX) has laid out its plans to integrate the newly acquired Bausch + Lomb into the corporate family. And true to form, CEO J. Michael Pearson ...

Chile’s CFR wins shareholder OK for Adcock buyout financing

Tracy Staton Chilean drugmaker CFR Pharmaceuticals is one step closer to its goal of buying South Africa's Adcock Ingram. CFR shareholders approved a $ 750 million increase in ...

Ipsen bags a development platform with $207M Syntaxin buyout

John Carroll The French company has struck a deal to buy the biotech and its drug development platform for $ 37 million upfront with promises of about $ 170 million more, with most ...

Buzz: Why is Roche considering a big buyout of Alexion?

John Carroll Shares of the rare disease drug specialist Alexion spiked 18% this afternoon after Bloomberg reported that Roche has been putting out feelers to raise cash for a big buyout. ...

Buzz: Why is Roche considering a big buyout of Alexion?

John Carroll Shares of the rare disease drug specialist Alexion spiked 18% this afternoon after Bloomberg reported that Roche has been putting out feelers to raise cash for a big buyout. ...

Mylan’s $1.6B Agila buyout hits snag in India amid cancer drug worries

Tracy Staton Mylan agreed to pay $ 1.6 billion for Agila Specialties, the injectables unit of Strides Arcolab. But Indian regulators are said to be skeptical of the deal, worried about ...

Pharmstandard to spin off OTC biz amid talks for $630M Bever buyout

Carly Helfand After reportedly weighing a sale of its $ 2.5 billion OTC business, Russia's Pharmstandard took matters into its own hands early this week, spinning off the ...

Onyx shares skyrocket on report of Amgen buyout offer

John Carroll FierceBiotech News

Buyout buzz: Royalty might mount joint effort to acquire Elan

Ryan McBride In the latest twist in Royalty Pharma's plot to buy Elan, the business press has caught wind that Royalty may decide to revive its pursuit of Elan with the help and ...

KKR scoops up global CRO PRA in $1.3B buyout deal

John Carroll FierceBiotech News
Page 5 of 7« First...34567
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS